Adverum Biotechnologies Inc.

In News

Lilly to Acquire Adverum Biotechnologies - PR Newswire

PR Newswire - Oct 24, 2025

Adverum Biotechnologies, Inc. Announces Two-Year Data from LUNA Phase 2 Trial - TradingView

TradingView - Dec 04, 2025

Adverum Biotechnologies Releases Promising Phase 2 Trial Data - TipRanks

TipRanks - Dec 04, 2025

Insider Selling: Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells $2,197,906.40 in Stock - MarketBeat

MarketBeat - Dec 07, 2025

Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration - Yahoo Finance

Yahoo Finance - Sep 22, 2025

Eli Lilly bets on eye care with buyout of gene therapy developer Adverum - Reuters

Reuters - Oct 24, 2025

Lilly to Buy Adverum in Bet on Gene Therapy for Eye Disease - Bloomberg.com

Bloomberg.com - Oct 24, 2025

Lilly to purchase Adverum Biotechnologies - Eyes On Eyecare

Eyes On Eyecare - Oct 29, 2025

ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders - Business Wire

Business Wire - Oct 27, 2025

What analysts say about Adverum Biotechnologies Inc stock - Earnings Per Share Trends & Try Our Free Strategy Builder Now - earlytimes.in

earlytimes.in - Dec 06, 2025

Adverum Biotechnologies (NASDAQ:ADVM) Major Shareholder Sells $1,260,000.00 in Stock - MarketBeat

MarketBeat - Dec 05, 2025

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners may be pleased with recent gains after 28% loss over the past year - Yahoo Finance

Yahoo Finance - Oct 03, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment